Wolverine (BPC-157 + TB-500)

Description

Wolverine is a combination reference preparation that pairs two regeneration-associated peptides: BPC-157, a tissue-protective pentadecapeptide, and TB-500, a thymosin beta-4 fragment that regulates cellular actin. The pairing is studied for how site-directed repair chemistry and systemic cell-migration signaling interact.

At a mechanism level the rationale combines BPC-157’s locally acting angiogenic and anti-inflammatory repair signaling with TB-500’s actin-regulating, systemically distributed regenerative activity, as characterized in preclinical tissue-repair research. Genefyx supplies Wolverine as a research reference material only, with a certificate of analysis; no dosing or administration guidance is provided, and it is not intended for human or animal use.

How it works

Combines BPC-157’s site-directed repair and anti-inflammatory action with TB-500’s systemic angiogenesis and actin-migration effect.

Research context

Sports-medicine and recovery research framing.

Handling

Lyophilized powder. Certificate of analysis, ≥99% purity.

Research use only. Not for animal or human consumption. Not approved or evaluated by the FDA — not a drug, supplement, or therapy. Price shown is a placeholder pending final pricing.